Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3679-3686
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3679
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3679
Table 2 Subgroup analyses for studies reporting on risk of colorectal cancer in patients with inflammatory bowel disease taking non-aspirin non-steroidal anti-inflammatory drugs
| No. of studies | Pooled OR (95%CI) | |
| Matched y/n | ||
| Matched/adjusted | 3 | 0.47 (0.18-1.13) |
| None | 5 | 1.04 (0.65-1.43) |
| Study location | ||
| Hospital | 6 | 0.92 (0.78-2.62) |
| Population | 2 | 0.88 (0.72-1.04) |
- Citation: Burr NE, Hull MA, Subramanian V. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease? World J Gastroenterol 2016; 22(13): 3679-3686
- URL: https://www.wjgnet.com/1007-9327/full/v22/i13/3679.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i13.3679